Energy Substrate Modulates Mitochondrial Structure and Oxidative Capacity in Cancer Cells

Comparative analysis of cytoplasmic organelles in a variety of tumors relative to normal tissues generally reveals a strong diminution in mitochondrial content and in oxidative phosphorylation capacity. However, little is known about what triggers these modifications and whether or not they are physiologically reversible. We hypothesized that energy substrate availability could play an important role in this phenomenon. The physiological effects of a change in substrate availability were examined on a human cancer cell line (HeLa), focusing specifically on its ability to use glycolysis versus oxidative phosphorylation, and the effect that energy substrate type has on mitochondrial composition, structure, and function. Changes in oxidative phosphorylation were measured in vivo by a variety of techniques, including the use of two novel ratiometric green fluorescent protein biosensors, the expression level of oxidative phosphorylation and some glycolytic enzymes were determined by Western blot, mitochondrial DNA content was measured by real-time PCR, and mitochondrial morphology was monitored by both confocal and electron microscopy. Our data show that the defective mitochondrial system described in cancer cells can be dramatically improved by solely changing substrate availability and that HeLa cells can adapt their mitochondrial network structurally and functionally to derive energy by glutaminolysis only. This could also provide an explanation for the enhancement of oxidative phosphorylation capacity observed after tumor regression or removal. Our work demonstrates that the pleomorphic, highly dynamic structure of the mitochondrion can be remodeled to accommodate a change in oxidative phosphorylation activity. We compared our finding on HeLa cells with those for nontransformed fibroblasts to help distinguish the regulatory pathways.

[1]  C. Hackenbrock,et al.  OXIDATIVE PHOSPHORYLATION AND ULTRASTRUCTURAL TRANSFORMATION IN MITOCHONDRIA IN THE INTACT ASCITES TUMOR CELL , 1971, The Journal of cell biology.

[2]  E. L. Springer Comparative study of the cytoplasmic organelles of epithelial cell lines derived from human carcinomas and nonmalignant tissues. , 1980, Cancer research.

[3]  A. John Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. , 2001, Medical hypotheses.

[4]  R. Gilkerson,et al.  The cristal membrane of mitochondria is the principal site of oxidative phosphorylation , 2003, FEBS letters.

[5]  J. M. Izquierdo,et al.  Mitochondrial Biogenesis in the Liver during Development and Oncogenesis , 1997, Journal of bioenergetics and biomembranes.

[6]  I. Scheffler,et al.  Energy metabolism in respiration‐deficient and wild type chinese hamster fibroblasts in culture , 1976, Journal of cellular physiology.

[7]  Otto Warburn,et al.  THE METABOLISM OF TUMORS , 1931 .

[8]  John C Reed,et al.  The bioenergetic signature of cancer: a marker of tumor progression. , 2002, Cancer research.

[9]  V. Centonze,et al.  Measurement of mitochondrial pH in situ. , 2001, BioTechniques.

[10]  G. Brierley,et al.  Estimation of intramitochondrial pCa and pH by fura-2 and 2,7 biscarboxyethyl-5(6)-carboxyfluorescein (BCECF) fluorescence. , 1987, Biochemical and biophysical research communications.

[11]  P. Houghton,et al.  Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions. , 1991, Cancer research.

[12]  Devin Oglesbee,et al.  Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.

[13]  A comparative study of inner membrane enzymes and transport systems in mitochondria from R3230AC mammary tumor and normal rat mammary gland. , 1975, Cancer research.

[14]  T G Frey,et al.  The internal structure of mitochondria. , 2000, Trends in biochemical sciences.

[15]  H. Rottenberg,et al.  The measurement of transmembrane electrochemical proton gradients , 1975, Journal of bioenergetics.

[16]  J. Winther,et al.  Shedding light on disulfide bond formation: engineering a redox switch in green fluorescent protein , 2001, The EMBO journal.

[17]  J. Bereiter-Hahn,et al.  Dynamics of mitochondria in living cells: Shape changes, dislocations, fusion, and fission of mitochondria , 1994, Microscopy research and technique.

[18]  E. Boitier,et al.  Impairment of the mitochondrial respiratory chain activity in diethylnitrosamine-induced rat hepatomas: possible involvement of oxygen free radicals. , 1995, Cancer research.

[19]  S J Remington,et al.  Structural and spectral response of green fluorescent protein variants to changes in pH. , 1999, Biochemistry.

[20]  H. Reichmann,et al.  Ragged red or ragged blue fibers. , 1996, European neurology.

[21]  S. Rhee,et al.  Identification of a New Type of Mammalian Peroxiredoxin That Forms an Intramolecular Disulfide as a Reaction Intermediate* , 2000, The Journal of Biological Chemistry.

[22]  M. Nagino,et al.  Stimulated rat liver mitochondrial biogenesis after partial hepatectomy. , 1989, Cancer research.

[23]  Roger Y. Tsien,et al.  Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo , 1996, Current Biology.

[24]  D. Turnbull,et al.  An antigenomic strategy for treating heteroplasmic mtDNA disorders. , 2001, Advanced drug delivery reviews.

[25]  D. Nicholls The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. , 1974, European journal of biochemistry.

[26]  B. J. Hanson,et al.  Human Complex I Defects Can Be Resolved by Monoclonal Antibody Analysis into Distinct Subunit Assembly Patterns* , 2001, The Journal of Biological Chemistry.

[27]  H. Morris,et al.  Differences in total mitochondrial proteins and proteins synthesized by mitochondria from rat liver and Morris hepatomas 9618A, 5123C, and 5123tc. , 1978, Cancer research.

[28]  Roger Y. Tsien,et al.  Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis , 2000, Nature Cell Biology.

[29]  Saroj P. Mathupala,et al.  Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. , 2002, Biochimica et biophysica acta.

[30]  Bert Vogelstein,et al.  Somatic mutations of the mitochondrial genome in human colorectal tumours , 1998, Nature Genetics.

[31]  R. Abramson,et al.  Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Robinson Use of fibroblast and lymphoblast cultures for detection of respiratory chain defects. , 1996, Methods in enzymology.

[33]  J. Griffiths Causes and consequences of hypoxia and acidity in tumour microenvironments. , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[34]  L. Reitzer,et al.  Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. , 1979, The Journal of biological chemistry.

[35]  H. D. Hoberman Is there a role for mitochondrial genes in carcinogenesis? , 1975, Cancer research.

[36]  B CHANCE,et al.  The respiratory chain and oxidative phosphorylation. , 1956, Advances in enzymology and related subjects of biochemistry.

[37]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[38]  B. J. Hanson,et al.  Antibody-based approaches to diagnosis and characterization of oxidative phosphorylation diseases. , 2001, Mitochondrion.

[39]  D. Stocco,et al.  Characteristics of mitochondria isolated by rate zonal centrifugation from normal liver and Novikoff hepatomas. , 1980, Cancer research.

[40]  S. Hoyer,et al.  Cultivation in Glucose-Deprived Medium Stimulates Mitochondrial Biogenesis and Oxidative Metabolism in HepG2 Hepatoma Cells , 2002, Biological chemistry.

[41]  R. A. Huseby Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression. , 1983, Cancer research.

[42]  M. Ott,et al.  Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. , 1998, Anticancer research.

[43]  W. Zwerschke,et al.  Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7 , 2001, Oncogene.

[44]  Keshav K. Singh,et al.  Mitochondrial DNA determines the cellular response to cancer therapeutic agents , 1999, Oncogene.

[45]  R. Gilkerson,et al.  Mitochondrial DNA depletion causes morphological changes in the mitochondrial reticulum of cultured human cells , 2000, FEBS letters.

[46]  P. Pedersen,et al.  Tumor mitochondria and the bioenergetics of cancer cells. , 1978, Progress in experimental tumor research.

[47]  Kathy Pfeiffer,et al.  Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.

[48]  S. Chaturvedi,et al.  Amplification and Attribution Styles in Somatoform and Depressive Disorders – A Study from Bangalore, India , 2003, Psychopathology.

[49]  Marc Dellian,et al.  Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  A Miyawaki,et al.  Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.